Related Experiment Videos
A rapid screening tool for estimating the potential of 2-hydroxypropyl-beta-cyclodextrin complexation for
Adriana Trapani1, Angela Lopedota, Nunzio Denora
1Dipartimento Farmaco-Chimico, Facoltà di Farmacia, Università degli Studi di Bari, Via Orabona 4, 70125 Bari, Italy.
International Journal of Pharmaceutics
|April 26, 2005
Summary
Quantitative structure-property relationships (QSPRs) models were created to predict solubility enhancement for drugs using hydroxypropyl-beta-cyclodextrin (HP-beta-CD). These models accurately estimate solubility increases for poorly soluble compounds during early drug development.
Area of Science:
- Pharmaceutical Sciences
- Computational Chemistry
- Drug Delivery
Background:
- Poorly water-soluble drugs pose formulation challenges.
- Hydroxypropyl-beta-cyclodextrin (HP-beta-CD) is used to enhance drug solubility.
- Predictive models are needed for efficient formulation development.
Purpose of the Study:
- To develop Quantitative Structure-Property Relationship (QSPR) models.
- To predict the solubility enhancement (logS/S0) of drugs in 45% HP-beta-CD aqueous solution.
- To aid formulation scientists in early-stage drug development.
Main Methods:
- Utilized a training set of 25 structurally diverse drugs with known logS/S0 values.
- Calculated 13 molecular descriptors including size, lipophilicity, and hydrogen-bonding capacity.
- Employed multivariate analysis, including Principal Component Analysis (PCA), cluster analysis, Multiple Linear Regression (MLR), and Partial Least Squares-Projection to Latent Structures (PLS).
Main Results:
- Developed two reliable four-descriptor QSPR models using MLR and PLS.
- Achieved satisfactory coefficients of determination (R² = 0.793 for MLR, R² = 0.763 for PLS).
- Validated models using a test set of six compounds, demonstrating reasonable predictive accuracy.
Conclusions:
- The developed QSPR models accurately predict aqueous solubility enhancement by HP-beta-CD complexation.
- These models provide a valuable tool for rapidly estimating the potential of HP-beta-CD for poorly soluble drugs.
- Facilitates efficient formulation strategies and accelerates early drug development stages.